
Carrier tapes deliver precise dosages that can be pure API; canister technology improves pressurized dose delivery

Carrier tapes deliver precise dosages that can be pure API; canister technology improves pressurized dose delivery


Private and public sectors can collaborate to achieve meaningful reform

More so than other classes of drugs, making choices about drugs for mental health conditions require everyone around the patient to be well informed

While storm clouds gather over pharma sales activities, marketers look to e-sampling as a potential alternative

US market will enter negative growth this year, says IMS Health


A 3.8% CAGR will rise to 8.0% for 2009-2013, says Kalorama Information

AcuTemp remains the only FAA-approved container for domestic US use

Medical and economic results from Diabetes Ten City Challenge show significant benefits in patient health, lower healthcare costs—and higher pharmaceutical usage

New Valdosta, GA, facility is targeted at independent pharmacies in the Southeast

War-gaming analyst picks the drug distributor over Microsoft, Allscripts and other EMR players

States pile on rules; industry wishes for consistency

Model N’s annual analysis of commercial operations finds lost revenue and a lack of IT tools

States continue to push for a ‘bio-economic’ foundation


The current economic downturn may fuel the creation of new, more sustainable business models


Specialty manufacturers have a range of options to consider in how to go to market

Spurred by some recent successful launches, and with hefty R&D funding commitments, the vaccine business is booming

Sustainability initiatives add to the complexity of managing reverse logistics for life sciences products

States continue to push for a ‘bio-economic’ foundation

Drug sponsors have options in both how the new FDA risk programs are structured and how to execute them

As direct-to-consumer advertising declines, vendors offer tactical aids to marketers

Supply-chain monitoring program to be run by healthcare-analytics company


Deals illustrate big pharma’s growing reliance on formerly eschewed market sectors

New metrics to factor into drug approvals

Poor reconciliation of chargebacks, plus faulty product-returns crediting, are the sources, says Health Industry Insights. Product serialization will provide invaluable tools, but industry shouldn’t wait for widespread adoption